Blood Clots & Nattokinase.

Contents.

A. Take home message.

B. Introduction.

C. Warfarin (Coumadin).

D. Aspirin.

E. Plasmin.

F. Nattokinase.

G. Aspirin and Prostate Cancer

[PCa] studies.

H. D-dimer.

I. Fibrinogen.

J. Warfarin & PCa Risk.

Caution: Nattokinase is an over-the-counter enzyme that dissolves blood clots. As of writing, there are six trials on clinicaltrials.gov, but none involve diagnosed deep vein thrombosis [DVT] or cancer. The author’s experience of nattokinase use for DVT and cancer should be viewed as anecdotal.

[A] Take home message.

Men at risk should keep an eye on D-dimer, which is elevated when there is a clot. If a clot is suspected, consider using nattokinase. This might speed up the breakdown of the clot. In the short term, this will increase D-dimer. Eventually, at an effective dose, D-dimer should fall close to zero. A maintenance dose might keep it there.

[B] Introduction.

A “deep vein thrombosis {DVT}, pulmonary embolism {PE}, or both, affects an estimated 300,000-600,000 individuals in the U.S. each year, causing considerable morbidity and mortality.” [Ba]

“The precise number of people affected by DVT/PE is unknown, although as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the United States” [Bb]

I don’t know why the CDC (Centers for Disease Control and Prevention) is so muddy about the actual number, but let’s suppose that well over a thousand individuals – 500 men – experience an event each day in the U.S. It isn’t as though these people were suddenly hit by lightni